170 related articles for article (PubMed ID: 1663250)
1. Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function.
Thompson WJ
Pharmacol Ther; 1991; 51(1):13-33. PubMed ID: 1663250
[TBL] [Abstract][Full Text] [Related]
2. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
Barnette MS; Manning CD; Price WJ; Barone FC
J Pharmacol Exp Ther; 1993 Feb; 264(2):801-12. PubMed ID: 7679736
[TBL] [Abstract][Full Text] [Related]
3. Isozyme-selective cyclic nucleotide phosphodiesterase inhibitors: biochemistry, pharmacology and therapeutic potential in asthma.
Raeburn D; Souness JE; Tomkinson A; Karlsson JA
Prog Drug Res; 1993; 40():9-32. PubMed ID: 8395068
[No Abstract] [Full Text] [Related]
4. Role of cyclic nucleotide phosphodiesterase isoenzymes in contractile responses of denuded rat aorta related to various Ca2+ sources.
Noguera MA; Ivorra MD; Lugnier C; D'Ocon P
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):612-9. PubMed ID: 11414656
[TBL] [Abstract][Full Text] [Related]
5. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes.
Nicholson CD; Challiss RA; Shahid M
Trends Pharmacol Sci; 1991 Jan; 12(1):19-27. PubMed ID: 1848733
[TBL] [Abstract][Full Text] [Related]
6. [Progress in the study of cyclic nucleotide phosphodiesterases].
Zhou HL; Bian RL
Sheng Li Ke Xue Jin Zhan; 1995 Jul; 26(3):213-7. PubMed ID: 8584886
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of isoenzymes of cyclic nucleotide phosphodiesterase in human kidney and heart, and the effects of new cardiotonic agents on these isoenzymes.
Sugioka M; Ito M; Masuoka H; Ichikawa K; Konishi T; Tanaka T; Nakano T
Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):284-93. PubMed ID: 7824045
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram.
Shahid M; Nicholson CD
Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):698-705. PubMed ID: 1710786
[TBL] [Abstract][Full Text] [Related]
9. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
Souness JE; Diocee BK; Martin W; Moodie SA
Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
[TBL] [Abstract][Full Text] [Related]
10. [Cyclic nucleotide phosphodiesterases: diversity, classification, structure and function].
Rascón A
Acta Cient Venez; 1997; 48(3):145-53. PubMed ID: 9640674
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors.
Dent G; Giembycz MA; Rabe KF; Barnes PJ
Br J Pharmacol; 1991 Jun; 103(2):1339-46. PubMed ID: 1653070
[TBL] [Abstract][Full Text] [Related]
12. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
[TBL] [Abstract][Full Text] [Related]
13. Assessment of phosphodiesterase isozyme contribution in cell and tissue extracts.
Keravis T; Thaseldar-Roumié R; Lugnier C
Methods Mol Biol; 2005; 307():63-74. PubMed ID: 15988055
[TBL] [Abstract][Full Text] [Related]
14. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
Torphy TJ; Cieslinski LB
Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
[TBL] [Abstract][Full Text] [Related]
15. Effects of the cyclic nucleotide phosphodiesterase inhibitors, rolipram, 3-isobutyl-1-methylxanthine, amrinone and zaprinast, on pancreatic exocrine secretion in dogs.
Iwatsuki K; Horiuchi A; Ren LM; Chiba S
Eur J Pharmacol; 1991 Dec; 209(1-2):63-8. PubMed ID: 1726088
[TBL] [Abstract][Full Text] [Related]
16. Modulation of relaxant responses evoked by a nitric oxide donor and by nonadrenergic, noncholinergic stimulation by isozyme-selective phosphodiesterase inhibitors in guinea pig trachea.
Ellis JL; Conanan ND
J Pharmacol Exp Ther; 1995 Mar; 272(3):997-1004. PubMed ID: 7891355
[TBL] [Abstract][Full Text] [Related]
17. The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitors.
Shahid M; van Amsterdam RG; de Boer J; ten Berge RE; Nicholson CD; Zaagsma J
Br J Pharmacol; 1991 Oct; 104(2):471-7. PubMed ID: 1665737
[TBL] [Abstract][Full Text] [Related]
18. Cardiac cGMP-stimulated cyclic nucleotide phosphodiesterases: effects of cGMP analogues and drugs.
Komas N; Le Bec A; Stoclet JC; Lugnier C
Eur J Pharmacol; 1991 Jan; 206(1):5-13. PubMed ID: 1648496
[TBL] [Abstract][Full Text] [Related]
19. 3',5'-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition.
Drees M; Zimmermann R; Eisenbrand G
Cancer Res; 1993 Jul; 53(13):3058-61. PubMed ID: 8391385
[TBL] [Abstract][Full Text] [Related]
20. Molecular structure, localization, and possible functions of the myelin-associated enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase.
Vogel US; Thompson RJ
J Neurochem; 1988 Jun; 50(6):1667-77. PubMed ID: 2836557
[No Abstract] [Full Text] [Related]
[Next] [New Search]
